Case series evaluates AngioJet™ thrombectomy for salvaging thrombosed arteriovenous fistulas in CKD patients, suggesting potential benefits.
Arteriovenous fistula patency is crucial, as it serves as a lifeline for chronic kidney disease (CKD) patients by enabling uninterrupted, effective dialysis–an essential determinant of survival and quality of life. This case series evaluates the AngioJet™ Peripheral Thrombectomy System (Boston Scientific, Marlborough, MA, USA) in the management of thrombosed arteriovenous fistulae in CKD patients undergoing hemodialysis.
No takes yet. Share an insight, caveat, or question.
Rajakumar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: